研報掘金丨東北證券:中國銀河多項指標均位於行業前列,首予“買入”評級
東北證券研報指出,中國銀河(601881.SH)實控人為中央匯金,股東實力雄厚,為公司發展提供較多資源和有力支撐。首次覆蓋給予“買入”評級。公司經營穩健,多項指標均位於行業前列。截至2023年三季度末,公司資產規模為6763.2億元,排名行業第5,較之2022年上升1名。同時,公司營業收入規模、歸母淨利潤規模均位於行業第4名,較之2017年分別提升5名和6名,財務槓桿倍數與ROE均位於行業第6 名,較之2017年分別提升16名和25名,對比同業優勢日益凸顯。中國銀河投行業務發展目標為到2025年打造國內一流投行,強化公司短板業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.